Ironwood Pharmaceuticals (IRWD) Profit After Tax (2010 - 2026)

Ironwood Pharmaceuticals (IRWD) has 17 years of Profit After Tax data on file, last reported at $40.8 million in Q1 2026.

• For the quarter ending Q1 2026, Profit After Tax rose 209.06% year-over-year to $40.8 million; the trailing twelve-month figure through Mar 2026 stood at $102.2 million (up 415.9% YoY), and the FY2025 full-year result was $24.0 million, up 2629.2% from the prior year.
• Profit After Tax climbed to $40.8 million in Q1 2026, from -$2.3 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $50.3 million in Q3 2022 to a low of -$1.1 billion in Q2 2023.
• A 5-year average of -$46.5 million and a median of $14.0 million in 2023 frame the typical range for Profit After Tax.
• Across the five-year window, Profit After Tax sank 3038.18% in 2023 and surged 2844.07% in 2025, its largest moves.
• Tracing IRWD's Profit After Tax over 5 years: stood at $48.9 million in 2022, then plunged by 103.57% to -$1.7 million in 2023, then surged by 229.28% to $2.3 million in 2024, then tumbled by 200.89% to -$2.3 million in 2025, then surged by 1891.43% to $40.8 million in 2026.
• Business Quant data shows IRWD's Profit After Tax at $40.8 million in Q1 2026, -$2.3 million in Q4 2025, and $40.1 million in Q3 2025.